APA (7th ed.) Citation

A, W., J, L., K, I., S, I., K, O., S, H., . . . T, W. (2025). UBE2T promotes epithelial-mesenchymal transition and motility in oral cancer cells via induction of IL-6 expression. Oncology letters, 30(4), 473. https://doi.org/10.3892/ol.2025.15219

Chicago Style (17th ed.) Citation

A, Watanabe, et al. "UBE2T Promotes Epithelial-mesenchymal Transition and Motility in Oral Cancer Cells via Induction of IL-6 Expression." Oncology Letters 30, no. 4 (2025): 473. https://doi.org/10.3892/ol.2025.15219.

MLA (9th ed.) Citation

A, Watanabe, et al. "UBE2T Promotes Epithelial-mesenchymal Transition and Motility in Oral Cancer Cells via Induction of IL-6 Expression." Oncology Letters, vol. 30, no. 4, 2025, p. 473, https://doi.org/10.3892/ol.2025.15219.